DEVELOPING A NOVEL PROTAC-BASED NR4A1 DEGRADER FOR BREAST CANCER THERAPY

$571,404FY2021Defense Health AgencyDOD

University Of Florida, Gainesville FL

Investigators

View source on USAspending →